1Vivier E,Tomasello E,Paul P.Lymphocyte activation via NKG2D:towards a new paradigm in immune recognition[J].Curt Opin Immunot,2002,14(3):306-311.
2Diefenbach A,Raulet DH.The innate immune response to tumors and its role in the induction of T-cell immunity[J].Immunol Rev,2002,188(1):9-21.
3Sutherland CL,Chalupny NJ,Sehooley K,et al.UL16-binding proteins,novel MHC class I-related proteins,bind to NKG2D and activate multiple signaling pathways in primary NK cells[J].J Immunol,2002,168(2):671-679.
4Holmes MA.Li P,Petersdorf EW,et al.Structural studies of allelic diversity of the MHC class I homolog MIC-B,a stress-inducible ligand for the activating immunoreceptor NKG2d[J].J Immunol,2002,169(3):1395-1400.
5Ho EL,Carayannopoulos LN,Poursine-Laurent J,et al.Costimulation of multiple NK cell activation receptors by NKG2D[J].J Immunol,2002,169(7):3667-3675.
6Roberts Al,Lee L,Schwarz E,et al.NKG2D receptors induced bv IL-15 costimulate CD28-negative effeeter CTL in the tissue microenvironment[J].J Immunol,2001,167(10):5527-5530.
7Gilfillan S,Ho EL,Celia M,et al.NKG2d recruits two distinct adapters to trigger NK cell activation and costimulation[J].Nat Immunol.2002,3(12):1150-1155.
8Diefenbach A,Tomasello E,Lucas M,et al.Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D[J].Nat Immunol,2002,3(12):1142-1149.
9Zompi S,Hamerman JA,Ogasawara K,et al.NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases[J].Nat Immunol,2003,4(6):565-572.
1Yuen MF,Norris S.Expression of inhibitory receptors in natural killer (CD3- CD56 + ) cells and CD3 + CD56+ cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma[J].Clin Immunol ,2001
2Pende D,Cantoni C,Rivera P,et al.Role of NKG2D in tumor cell lysis mediated by human NK cells:cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin[J].Eur J ImMunol ,2001,31(4):1076-1086.
3Vivier E,Tomasello E,Paul P.Lymphocyte activation via NKG2D:towards a new paradigm in immune recognition[J].Curr Opin Immunol ,2002,14(3):306-311.
4Jamieson AM,Diefenbach A,McMahon CW,et al .The role of the NKG2D immunoreceptor in immune cell activation and natural killing[J].Immunity ,2002,17(1):19-29.
5Groh V,Wu J,Yee C,et al .Tumour-derived soluble MIC ligands impair expression of NKG2D and T cell activation[J].Nature ,2002,419(6908):734-738.
6Menier C,Riteau B,Carosella ED,et al .MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal[J].Int J Cancer ,2002,100(1):63-70.
8Wang H,Yang D,Xu W,et al.Tumor-derived soluble MICs impair CD,(+) CD56(+) NKT-like cell cytotoxicity in cancer patients.Immunol Lett,2008,120:65-71.
9Kaiser BK,Yim D,Chow IT,et al.Disulphide-isomerase-enabled shedding of tumor-associated NKG2D ligands.Nature,2007,447:482-486.
10Jinushi M,Vanneman M,Munshi NC,et al.MHC class I chainrelated protein A antibodies and shedding are associated with the progression of multiple myeloma.Proc Natl Acad Sci USA,2008,105:1285-1290.
